"Blood is a pool of tumor cells and products released from primary and metastatic lesions. Hence more comprehensive information can be obtained by the analysis of blood or other body fluids" Dr Klaus Pantel (Chairman, Institute of Tumour Biology, Germany) https://t.co/LWus6vDSz9
Exciting start to Best of ASCO at Pune! Dr T Raja, a renowned oncologist honored us with his presence at our @onecelldx and @oncodiscover Pune Lab. It was an insightful discussion with @KhandareJayant & our team of brilliant scientists. Thank you @TRaja_AHEL for visiting us!
Exciting updates and groundbreaking research is being showcased at #ASCO2023! The #oncology community is shaping the future of cancer treatment. Grateful for the dedicated scientists, clinicians, and patients who continue to push boundaries. Together, we can conquer #cancer!
@liddiard_harry The projected growth of the global #cancer#Immunotherapy market to $119.4 billion is promising. However, we must acknowledge the challenges like availability, awareness, development, approvals and cost in ensuring widespread access to these life-saving treatments.
Red Cross is not just about emergency response, they are also involved in supporting #cancer patients & their families. On #WorldRedCrossDay2023 We express our gratitude to all those who work tirelessly to make a positive impact in the world. @jayantkhandare
Thrilled with the success of poster 1 of 3 at #AACR The Reception and applause on our work at circulating tumor cells/CtDNA in #precisiononcology were incredible. Exciting to see how rapidly this field is advancing! Congratulations @KhandareJayant@GowharShafi on a funfilled day
@Dr_R_Kurzrock Congratulations on setting up KurzrockLab at McW! Your dedication to uncovering innovative treatment options shows your commitment to advancing the field of oncology and improving patient care. Wishing you all the best!
@pashtoonkasi Agreed, brain metastases pose a unique challenge for patients and oncologists. It's encouraging to see promising results with T-DXd in this patient after just one dose. Research and development of treatments targeting the blood-brain barrier are crucial for improving outcomes.
@Dr_R_Kurzrock It's interesting to note that this correlation exists independent of the percentage of #ctDNA. This underscores the importance of continued research into #liquidbiopsies and their potential to improve #cancerdiagnosis and treatment.
Acquiring tissue for advanced lung cancer diagnosis and comprehensive biomarker testing: A National Lung Cancer Roundtable best-practice guide
#lungcancer#PrecisionOncology#cancerdiagnosis
https://t.co/j9eIzvsrgW
The potential of #ctDNA as an early endpoint for decision-making during drug development and a tool to inform treatment decisions #oncology#precisiononcology#NSCLC
https://t.co/fbKTth3xEu